https://www.mpssociety.ca/efficacy-and-safety-of-pabinafusp-alfa/
Recruiting for Clinical Trial: MPS-II (Hunter Syndrome) with Pabinafusp-Alfa - mpssociety
Apr 30, 2022 - Mathias Schmidt, PhD, President and CEO of JCR Pharmaceuticals USA, discusses long-term efficacy and safety data of pabinafusp-alfa (Izcargo) in...
clinical trialmps ii